NovaBay Pharmaceuticals, Inc. Logo

NovaBay Pharmaceuticals, Inc.

Develops and commercializes eyecare, skincare, and wound care products.

NBY | US

Overview

Corporate Details

ISIN(s):
US66987P2011
LEI:
Country:
United States of America
Address:
2000 POWELL STREET, SUITE 1150, 94608 EMERYVILLE

Description

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company that develops and commercializes scientifically-created and clinically-proven products for the eyecare, skincare, and wound care markets. The company's core technology is a proprietary, stable formulation of hypochlorous acid. Its leading product is Avenova®, an antimicrobial lid and lash solution available over-the-counter for eye hygiene. In the wound care sector, NovaBay manufactures and sells products under the NeutroPhase® and PhaseOne® brands, which utilize its hypochlorous acid technology to aid in cleansing and debridement. The company focuses on providing accessible, problem-solving solutions for improved well-being.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all NovaBay Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NovaBay Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NovaBay Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

KoBioLabs, Inc. Logo
Develops microbiome-based therapeutics for immune, metabolic, and brain disorders.
South Korea
348150
Kodiak Sciences Inc. Logo
Clinical-stage biopharma developing therapeutics for chronic retinal diseases.
United States of America
KOD
Kohjin Bio Co., Ltd. Logo
Develops and sells culture media, biological materials, and diagnostics for research.
Japan
177A
KOLON LIFE SCIENCE Inc. Logo
Develops cell/gene therapies and manufactures APIs and specialty chemicals.
South Korea
102940
Kolon TissueGene, Inc. Logo
A clinical-stage biopharma developing cell and gene therapies for orthopedic diseases.
United States of America
950160
Biopharmaceutical company developing products for animal and human health.
South Korea
041960
KOREA ARLICO PHARM CO.,LTD. Logo
Develops, manufactures, and sells generic and other pharmaceutical products.
South Korea
260660
Develops, manufactures, and markets pharmaceuticals and other healthcare products.
South Korea
014570
Develops and produces prescription medicines with a focus on Central Nervous System drugs.
South Korea
032300
KOREA UNITED PHARM INC Logo
Pharmaceutical firm developing and manufacturing drugs for global export.
South Korea
033270

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.